Powered by

Weekly: Abattis Bioceuticals in its biggest weekly gain in 2 months

Feb 03, 2017 - News Bites Canadian Markets

CANADIAN WEEKLY STOCK REPORT

Abattis Bioceuticals Corp. (CNSX:ATT), Canada's 42nd largest Biotechnology company by market cap, has lifted 1.50c (or 11.5%) in the past week to close at 14.50c. In the past week the shares have lifted 11.5%, the biggest weekly gain since December 16, 2016. Compared with the S&P/TSX 60 Index which fell 7.2 points (or 0.8%) in the week, this represented a relative price increase of 12.3%. The volume in the week equalled the average trading of 3.5 million shares...